Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 40 Colorectal Neoplasms 25 Colonic Neoplasms 10 Brain Neoplasms 8 Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Neoplasm Metastasis 6 Rectal Neoplasms 5 Skin Neoplasms 4 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Pancreatic Neoplasms 2 Digestive System Neoplasms 2 Thyroid Neoplasms 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Solid Tumors 1 Solid Tumor 1 Skin Diseases 1 Recurrence 1 Rectal Diseases 1 Neurofibromatosis 1 1 Multiple Myeloma 1 Lymphatic Metastasis 1 Leukemia, Hairy Cell 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematologic Neoplasms 1 Gliosarcoma 1 Glioma 1

Interventions

Gemcitabine 95 Cisplatin 72 Capecitabine 39 Oxaliplatin 38 durvalumab 29 Fluorouracil 27 pembrolizumab 26 Leucovorin 23 S 1 (combination) 19 Nivolumab 14 Irinotecan 14 lenvatinib 13 Bevacizumab 13 tremelimumab 10 130-nm albumin-bound paclitaxel 9 apatinib 8 Trastuzumab 7 Injections 7 Immune Checkpoint Inhibitors 7 Docetaxel 7 Albumin-Bound Paclitaxel 7 Paclitaxel 6 Drug Therapy 6 titanium silicide 5 surufatinib 5 irinotecan sucrosofate 5 gemcitabine-oxaliplatin regimen 5 envafolimab 5 camrelizumab 5 atezolizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × encorafenib × Clear all

NCT05615818 2026-05-19

SAFIR-ABC10

UNICANCER

Phase 3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡